HR 10628
Biosimilars Access and Affordability Act
HR 10628 (119th Congress) is federal legislation introduced in the U.S. House of Representatives on September 28, 2026.
Current status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2026-09-28).
Summary
Sponsors
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2026-09-28